InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Duncan Gregory Scott, 首席执行官. Insider active across 2 companies, notably Virios Therapeutics, Inc.. Aggregated, 6 filings have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €85k. History available since 21 December 2021. The latest transaction was disclosed on 26 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Duncan Gregory Scott is Directeur Général. He has 6 filings in total, and across the 6 recent filings tracked, acquisitions span the period from 2021-12-22 to 2026-01-27, with buy volume of EUR 84954 and no sell volume; the companies mentioned are CorMedix Inc. and Virios Therapeutics, Inc.